UNIHA-Fourniture de Médicaments Dérivés du Sang, recombinants et issus de Thérapie Génique
Original notice title
UNIHA Fourniture de Médicaments Dérivés du Sang, recombinants et issus de Thérapie Génique
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
60 / 100
Risk factors
No estimated value, award criteria, or detailed selection criteria are provided. This significantly increases uncertain...
Tenders must be in French; non-French speakers may face translation costs and risks.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration 45 MONTH
- Supply of blood-derived medicinal products, recombinant medicinal products, and gene therapy medicinal products.
- Dynamic purchasing system (DPS) and framework agreement for a group of contracting authorities coordinated by Uni.H.A.
Show full summary
This tender by Hospices Civils de Lyon (France) establishes a Dynamic Purchasing System (DPS) and framework agreement for blood-derived, recombinant, and gene therapy medicinal products. It covers a single lot with a 45-month duration. The deadline for submission is 31 July 2029. No estimated value is provided. Submission is electronic and must be in French. Selection criteria are vaguely defined as 'Critères Divers' (various criteria). Award criteria are absent from the provided data. The tender is open to SMEs and involves no EU funding.
Risks
No estimated value, award criteria, or detailed selection criteria are provided. This significantly increases uncertain...
Tenders must be in French; non-French speakers may face translation costs and risks.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must comply with Directive 2014/24/EU.
Administrative
- Electronic submission via www.marches-publics.gouv.fr.
- Tenders must be submitted in French.
Requirements may be incomplete.
Buyer
Name
Hospices Civils de Lyon
Location
Lyon Cedex 08, FRA
Website
Buyer profile
Identifier
26690027300019
Lots (1)
LOT-0001
UNIHA-Fourniture de Médicaments Dérivés du Sang, recombinants et issus de Thérapie Génique
Dynamic acquisition system for blood-derived medicinal products, including recombinant and gene therapy products, managed by the groupement de commandes Uni.H.A. Place of performance is France.
Location
Duration
Category
Deadline
Award details
Additional CPV codes
Value note
Show original TED data
Original TED description
Les Hospices Civils de Lyon lance un système d'acquisition dynamique, en tant que pouvoir adjudicateur et coordonnateur pour le groupement de commandes Uni.H.A
Procurement Details
- Publication date
- 18 Nov 2025
- Notice type
- Contract notice — standard
- Languages
- French
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 766772-2025
- Source notice ID
- 7da76f95-e1d0-481d-bb63-63d0e9f2222b
Documents (1)
Similar tenders
Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB
Poland – Antithrombotic agents – Dostawa produktów leczniczych do leczenia zaburzeń w funkcjonowaniu przewodu pokarmowego, środków antybakteryjnych do użytku ogólnoustrojowego (...) w podziale na 21 części.
Croatia – Medicinal products for the blood and blood-forming organs – Lijekovi (koji nisu uključeni u postupak zajedničke nabave)
Bulgaria – Pharmaceutical products – „Доставка на противотуморни лекарствени продукти за лечение на хематологични заболявания, за нуждите на УМБАЛ „Александровска“ ЕАД”
Slovakia – Medicinal products for the blood and blood-forming organs – Lieky ATC skupiny B02BD05
Slovakia – Medicinal products for the blood and blood-forming organs – Lieky ATC skupiny B02BD02
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
60 / 100
Risk factors
No estimated value, award criteria, or detailed selection criteria are provided. This significantly increases uncertain...
Tenders must be in French; non-French speakers may face translation costs and risks.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications